Loading [Contrib]/a11y/accessibility-menu.js
info@auctorespublishing.com
+1-(302)-520-2644
+1-(302)-520-2644

Artificial intelligence: Can help Minimize Poor Outcomes and Challenges in Gynecology and Obstetrics?

  1. Home
  2. Journals
  3. Obstetrics Gynecology and Reproductive Sciences
  4. Archives
Submit Guidelines

Research Article | DOI: https://doi.org/10.31579/2578-8965/255

Artificial intelligence: Can help Minimize Poor Outcomes and Challenges in Gynecology and Obstetrics?

  • Sherif Sobhy Menshawy Khalifa 1*
  • Iman Abdul Ghani Alhalabi 2
  • Mohamed Zaeim Hafez 3

1Obstetrics and Gynecology Department, Faculty of Medicine, Menoufia University, Menoufia, Shebin El-Kom 32511, Egypt. 

2Specialist registrar Obstetrics and Gynecology, Latifa Hospital-Dubai Health, UAE.

3Physiology Department, Faculty of Medicine, Al-Azhar University, Assiut, Egypt. 

*Corresponding Author: Sherif Sobhy Menshawy Khalifa, Obstetrics and Gynecology Department, Faculty of Medicine, Menoufia University, Menoufia, Shebin El-Kom 32511, Egypt.

Citation: Menshawy Khalifa SS, Ghani Alhalabi IA, Mohamed Z. Hafez, (2025), Artificial intelligence: Can help Minimize Poor Outcomes and Challenges in Gynecology and Obstetrics?, J. Obstetrics Gynecology and Reproductive Sciences, 9(1) DOI:10.31579/2578-8965/255

Copyright: © 2025, Sherif Sobhy Menshawy Khalifa. This is an open-access article distributed under the terms of The Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: 26 December 2024 | Accepted: 31 December 2024 | Published: 06 January 2025

Keywords: artificial intelligence; gynecology and obstetrics; Fetal Echocardiography; poor outcomes

Abstract

Background: Artificial intelligence (AI) and Machine Learning (ML) have been the subject of discussion among many professionals, researchers, and managers working in the fields of gynecology and obstetrics. 

Objective: This work aims to review the role of Artificial intelligence in minimizing poor outcomes and challenges in gynecology and obstetrics. 

Results: Recently, the use of AI has gained traction in its ability to predict clinical outcomes using routinely obtained information, such as patient attributes, medical images, and blood test results. However, AI in healthcare systems requires collaboration and training among the partners for successful implementation. In conclusion, AI has become one of the significant components of life today and so is its requirement in medicine, especially in digital medicine. We conclude that AI has an important future in improving IVF success.

Introduction

Artificial intelligence (AI) is a branch of computer science that aims to create machines or systems that can perform tasks that normally require human intelligence, such as learning, reasoning, perception, decision-making, or natural language processing (Figure 1). AI has been widely applied in various fields of medicine and healthcare, such as disease diagnosis, drug discovery, patient risk assessment, and personalized treatment (Rajpurkar et al., 2022). AI has been revolutionizing discovery, diagnosis, and treatment designs in various fields of medicine, including gynecology (Brandão et al., 2024). AI can aid in the detection of gynecological disorders, therapy design, and identification of new therapeutic targets by accelerating drug discovery, and improving treatment outcomes (Li et al., 2021). Artificial Intelligence, machine learning, deep learning, and neural networks are some of the terms often used to describe the use of advanced computational methods to analyze large and complex data sets, such as those generated by clinical research, (Gupta et al. 2021). This technology has been actively used in gynecology and obstetrics (GYN/OB) and is now merged into daily medical practice. Various problems can arise during the diagnosis of a disease and AI helps to overcome those problems. AI can be a promising tool to resolve many challenges (Prabha, 2024). 

Figure 1. Hierachy of information processing theories in the computer science field. Artificial intelligence (AI) is an umbrella term attributed to the primary objective within the field of computer science to develop machines with intelligence. Machine learning describes approaches to achieve AI that learns from experience without explicit programming. Deep learning is a form of machine learning that utilizes artificial neural networks to extract, process, and predict information by learning from examples. It is commonly applied in the scientific field in image classification.

The need for the nexus of AI in obstetrics and gynecology

Obstetrics and gynecology are the debatable specialties that account for indemnity payments due to negligence claims. Besides litigation costs, socioeconomic consequences on a long-term basis due to medical errors have become detrimental (Vickers and Jha, 2020). Hypoxia-induced encephalopathy has become the most common confrontational event due to intrapartum fetal misinterpretation, which can be partially preventable. In addition, numerous poor outcomes and challenges have been recounted in gynecology, which is witnessed in gynecological oncology, where failed detection and prognosis of malignancy have been a major concern (Williams et al., 2019; Dillon et al., 2022). The conventional methodologies are considered inadequate in proffering treatment stratification on an individualized basis with various limitations. Infertility treatment has remained a major concern with traditional approaches. Thus, AI-assisted IVFs are instances of surging demands of AI in obstetrics and gynecology for enhanced success rates in treatment (Liu et al., 2020; Mapari et al., 2024).
In addition, the rapid markup of advancements in genetic engineering in IVF practice raised the need for AI to enhance precision. Traditional methods have always been the most important tool in addressing healthcare issues among women through evidence synthesis, clinical trials, etc. Nevertheless, the gray areas present within the traditional approaches have been the reason for failure in providing appropriate solutions in clinical practices. Thus, AI has become one of the significant components of life today and so is its requirement in medicine, especially in digital medicine (Ahmad et al., 2021). This lies in the fact that the progression of precision techniques has enabled accurate predictions in the healthcare domain as AI-based algorithms assist in meeting diagnostic challenges such as performance and efficiency in clinical services (Kalra et al., 2024). These algorithms also improve clinical attentiveness in monitoring and treating complex diseases, controlling infections, etc. This shows that there is a clear need for the intervention of AI in obstetrics and gynecology (Malani et al., 2023). 

Evolution and progress of AI in medicine

In the recent decade, there have been copious discussions about the AI position in the medicinal field, particularly focusing on big data management, assessment of algorithms, and medicolegal problems. The US Food and Drug Administration (FDA) has already endorsed various AI algorithms for the benefit of physicians and patients, and different organizations worldwide have followed the initiatives of the FDA (Bhattad and Jain, 2020). The applications of AI have assisted medical professionals and doctors in different domains, such as health information systems, syndromic and epidemic surveillance, geocoding of healthcare data, medical imaging, predictive models, and decision support systems (Jain et al., 2024). The AI system can provide health professionals with medical information with consistent and continuous real-time updates sourced from different textbooks, journals, clinical patients, and practices, which enables sophisticated and enhanced patient care and assists necessary inference for health outcomes prediction and health-risk assessment, specifically contributing to the field of gynecology and obstetrics (Drukker et al., 2020). The evolution of big data as an input to AI in the field of obstetrics and gynecology is shown in Figure 2.

A diagram of a medical data processing process Description automatically generated

Figure 2. Role of AI in reproductive medicine (Malani et al., 2023).

Applications of artificial intelligence in obstetrics

1.Diagnostic imaging and interpretation

AI is no longer a temporary social phenomenon or a topic only for specific scientific fields. Instead, it is a technical field that can help in improving diagnosis, treatment strategy, and clinical outcomes and overcoming various problems related to diagnosis even in the obstetric field. AI systems currently used for obstetric diagnostic purposes, such as fetal cardiotocography, ultrasonography, and magnetic resonance imaging, and demonstrates how these methods have been developed and clinically applied (Sarno et al., 2023).

Fetal Cardiotocography

Cardiotocography (CTG) was an early development in the field of obstetrics. CTG is the most important device for evaluating fetal well-being through measurements of the fetal heart rate and uterine contractions (Ahmed et al., 2024). The fetal heart rate pattern reflects fetal cardiac and central nervous system responses to hemodynamic changes. To overcome limitations in the interpretation of CTG by humans, AI using modern computer systems has been applied to CTG interpretation, and many experiments are underway (Salini et al., 2024). A recent systematic review concluded that machine learning interpretation of CTG during labor did not improve neonatal outcomes in terms of neonatal acidosis, cord blood pH <7>(Balayla and Shrem, 2019). A plausible reason for the limited efficacy is that the training for ML models of CTG was based on human interpretation. Therefore, an alternative approach that does not include human interpretation or guidelines in system development has been investigated in the context of feature engineering theory (Kim et al., 2022).

Ultrasonography

One safe, noninvasive technique for diagnosing pregnancies is US. Yet, despite its broad application, it can be challenging to obtain accurate readings in particular situations, including motion distortions, hazy borders, acoustic shadows, low signal-to-noise ratio, maternal obesity, and speckle noise, which make precise readings challenging (Benacerraf et al., 2018). ML has been used for several years to help with the automatic recognition and distinction of different fetal body parts through algorithms on US images of fetuses. Algorithms for obtaining and measuring biometric data and fetal features from US pictures have been developed in several research studies (Yousefpour et al., 2023; Fiorentino et al., 2023). For the time being, there is a semi-automated application for interpreting fetal ultrasonography; if a sonographer or doctor chooses the right pictures of each body component, the program employs an AI algorithm to automatically generate body measurements. Many businesses are getting ready to offer services relating to this technology, which is already in use. For example, automated standard scan planes have been established for quantifying fetal biparietal diameter and head circumference using three-dimensional transthalamic plane US pictures and two-dimensional transventricular US images of the fetal brain (Grandjean et al., 2018; Han et al., 2024). Further studies have demonstrated the efficacy of ML in recognizing embryonic organs and structures, which helps diagnose congenital anomalies (Burgos-Artizzu et al., 2019; Burgos-Artizzu et al., 2020).

Fetal Echocardiography

Fetal echocardiography (ECG) has only been used for 15 years; nonetheless, this imaging modality is essential for perinatal care in that it is very useful for diagnosing and monitoring intrauterine growth restriction, twin-to-twin transfusion syndrome, and congenital heart anomalies (Edwards and Arya, 2024). Monitoring fetal cardiac function with US is challenging due to involuntary movements of the fetus, the small fetal heart, the fast fetal heart rate, limited access to the fetus, and the lack of experts in fetal echocardiography. Automatic calculation of the fetal heartbeat has been carried out in many studies that have extracted the fetal heart rate from CTG using dimensionality reduction or measured fetal QRS complexes from maternal ECG recordings using ANN and pulse-wave Doppler envelope signals extracted from B-mode videos (Sulas et al., 2021; Mertes et al., 2022).  For cases with congenital heart anomalies, an intelligent navigation method referred to as "fetal intelligent navigation echocardiography (FINE)" was developed and this can detect four types of abnormalities (Weichert et al., 2023). Arnaout et al. demonstrated a deep learning method identifying the five most essential views of the fetal heart and segmentation of cardiac structures. They found that hypoplastic left heart syndrome was the most frequently distinguished anomaly compared to normal structures and tetralogy of Fallot at the gestational age of 18 to 24 weeks (Arnaout et al., 2021). 


MRI Interpretation

AI aids in interpreting MRI scans for conditions like endometriosis, fibroids, and ovarian tumors. AI-driven image analysis helps differentiate between benign and malignant masses, thereby aiding in early and accurate diagnosis. In obstetrics, MRI is a subject of active research alongside US. MRI is frequently used to distinguish various fetal brain conditions and evaluate the severity of placenta previa (Patel et al., 2019). For example, a particular study involved the automated extraction and analysis of fetal brain structures from MRI scans of 45 pregnant women, including automated volume measurements (Khalili et al., 2019). Another study utilized various AI techniques to analyze 59 MRI scans of fetuses with ventriculomegaly, predicting the need for postnatal interventions like cerebrospinal fluid diversion with 91

Cervical Cancer

Artificial intelligence (AI) has improved cervical cancer diagnosis and treatment in several ways. AI can help automate the evaluation of dual-stain tests, which measure the presence of two proteins (p16 and Ki-67) in cervical samples to predict the risk of precancer (Boon et al., 2022; Ouh et al., 2024). This can reduce the time and cost of screening, as well as increase the accuracy and efficiency of diagnosis. AI can also help analyze images of cervical cells or tissues, such as Pap cytology or histopathology, using complex algorithms that can automatically recognize, extract, and classify features (Li et al., 2020). This can improve the sensitivity and specificity of detecting precancerous or cancerous changes and reduce the variability and subjectivity of human interpretation (Yang et al., 2023). Artificial intelligence (AI) is a powerful tool that can help in the discovery of novel biomarkers for cervical cancer. Biomarkers are biological indicators that can be used for the diagnosis, treatment, and prognosis of cervical cancer (Aswathy et al., 2024). AI can analyze large and complex data sets generated by high-throughput omics technologies, such as genomics, transcriptomics, proteomics, and metabolomics, and identify patterns and associations that are relevant for cervical cancer (Zhang et al., 2024). AI can also assist in screening and diagnosis by analyzing digital images of the cervix and detecting precancerous changes that require medical attention (Dellino et al., 2024).

A machine learning model based on support vector machines (SVMs) was able to identify several microRNAs (miRNAs) as a biomarker for cervical cancer (Ding et al., 2021). The model used gene expression data from The Cancer Genome Atlas (TCGA) and achieved an accuracy of 93.3% and an AUC of 0.98 (Balakittnen et al., 2024). AI can use natural language processing (NLP) to extract relevant information from clinical records and literature to identify potential biomarkers for cervical cancer (Gholipour et al., 2023). Deep learning and machine learning can help create personalized treatment plans for cervical cancer patients by analyzing their genetic information, such as gene expression, mutation, or methylation. These data can be used to identify biomarkers that can indicate the prognosis, response, or resistance to certain drugs or therapies (Alharbi and Vakanski, 2023). AI and deep learning technology have been extensively used in analyzing genomic data for targeted therapy in cervical cancer. Genomic data can help in cervical cancer treatment by identifying the molecular profiles of different tumors and finding potential targets for therapy (Ma et al., 2022). 

Gynecological Hormonal Disorder

AI can help diagnose, treat, and prevent various diseases, including gynecological hormonal disorders (Agrawal et al., 2022). Gynecological hormonal disorders are conditions that affect the female reproductive system and are caused by an imbalance of hormones. Some examples of gynecological hormonal disorders are polycystic ovary syndrome (PCOS), endometriosis, uterine fibroids, and menopause (Bulun et al., 2019). 

Endometriosis

Endometriosis is characterized by the presence of endometrial-like tissue outside the uterus, which can cause inflammation, adhesions, scarring, and infertility (Rathod et al., 2024). AI has the potential to improve the diagnosis and treatment of endometriosis by analyzing different types of data, such as biomarkers, clinical variables, genetic factors, imaging data, and lesion characteristics. AI can also help to understand the underlying mechanisms and risk factors of endometriosis, as well as to predict the outcomes and responses to different therapies (Giudice et al., 2023, Avery et al., 2024, (Bendifallah et al., 2022). By integrating AI, three-dimensional cultures and organ-on-chip models, it is possible to achieve better understanding of physiopathological features and better tailored effective treatments, thereby helping to overcome some of the limitations of current animal models and cell lines in mimicking the complexity and heterogeneity of endometriosis (Deng et al., 2024). Machine learning techniques can be used to predict endometriosis based on previous records as well as genetics and epigenetics. A previous study used machine learning classifiers such as decision tree, partial least squares discriminant analysis, support vector machine, and random forest to analyze transcriptomics and methylomics data from endometriosis and control samples. The study identified several candidate biomarker genes such as NOTCH3, SNAPC2, B4GALNT1, SMAP2, DDB2, GTF3C5, PTOV1, TRPM6, RASSF2, TNIP2, RP3-522J7.6, FGD3, and MFSD14B1 (Akter et al., 2019). AI can potentially help in various aspects of diagnosis, treatment, and management of endometriosis and its associated symptoms (Kiser et al., 2024). AI can use various types of data, such as clinical, imaging, genetic, or molecular, to create predictive models that can help clinicians tailor the best treatment option for each patient. AI has a high accuracy and performance in predicting the response to treatment of endometriosis, especially when using multiple data sources or multimodal datasets (Qi et al., 2024).

Polycystic Ovarian Syndrome (PCOS)

Polycystic ovary syndrome (PCOS) is a hormonal disorder that affects millions of women around the world. It causes various physical and psychological symptoms, such as excessive body hair growth, irregular menstrual cycles, acne, obesity, infertility, and insulin resistance (Zeng et al., 2022).  One of the main applications of AI in PCOS is the detection and diagnosis of the syndrome using various methods, such as machine learning, deep learning, fuzzy logic, and computer vision (Khanna et al., 2023). These methods can analyze different types of data, such as clinical features, hormonal levels, ultrasound images, scleral images, and genetic markers, to identify PCOS patients and classify them into different phenotypes. AI can also help in predicting the risk of PCOS and its associated outcomes, such as metabolic syndrome, depression, anxiety, and quality of life (Verma et al., 2024). AI can help personalize the treatment of PCOS by considering the patient’s characteristics, preferences, and goals. For example, a study used reinforcement learning to optimize the dosage of metformin, a common drug for PCOS, based on the patient’s weight, insulin sensitivity, and ovulation status (Guixue et al., 2023). AI can help provide emotional support and guidance for women with PCOS who may experience psychological distress, such as depression, anxiety, and low self-esteem (Wang et al., 2023). For example, a study by used natural language processing to create a chatbot that can deliver cognitive behavioral therapy (CBT) for women with PCOS (Gbagbo et al., 2024). Another study used machine learning to design a mobile app that can provide psychoeducation and relaxation techniques for women with PCOS (Prapty and Shitu, 2020).

Gynecological surgery

In surgery, the application of physical AI has been utilized more than virtual AI. Virtual AI uses established patient factors, repetitive patterns, and treatment algorithms to predict the outcome, as opposed to the surgical field, which has many independent variables. Some of these variables are the consistency of different tissues, the skills of each surgeon, the changes that are done in the surgical field while operating, and unique differences between patients and their pathology; ultimately, these unique factors make it challenging to create an algorithm (Moawad et al., 2019). Areas in which AI has assisted gynecological surgery include those related to imaging and spatial awareness. AI can aid the surgeon by providing better imaging before and during surgery (Gumbs et al., 2021). The creation of three-dimensional printing (3DP) that replicates the surgical site is far superior to its two-dimensional (2D) counterpart, as it represents a more precise version of the actual model (Meyer-Szary et al., 2022). This allows a more accurate preoperative plan, hence diminishing errors in the operating room. 3DP can also provide different materials that can resemble the tissues that would be encountered, thus providing realistic practice for trainees and unprecedented preoperative planning (Iftikhar et al., 2020, Kannaiyan et al., 2024, Iftikhar et al., 2020). 

AI has also helped decrease operative time and accuracy, which subsequently decreases operative complications (Iftikhar et al., 2024). This has been done via the utilization of augmented reality. Augmented reality consists of a computer that can reconstruct objects taken from the real-world and enhance them virtually to create a more informative visual image (Vávra et al., 2017). One review of augmented reality in surgery summarizes some of the shortcomings of this technology, such as increased cost, concern for a latency of the system, and that the head-mounted display is heavy and impractical for long surgeries (Dirie et al., 2018).  Furthermore, augmented reality might cause nausea and vomiting due to “simulator sickness,” which would be less than ideal during surgery. Augmented reality might also demonstrate too much information and increase clutter, thus distracting the surgeon from the task on hand, and would be most helpful in an immobile structure so mobile organs (like the uterus) are not ideal for this technology. Despite certain disadvantages, it was concluded that there are positive benefits to augmented reality, such as increased precision, safety, and a time reduction in performing procedures (Iftikhar et al., 2020). 

Conclusion

There is still a very long way to go until AI-based technologies become perfectly integrated into everyday clinical decisions. AI has been developed as the most significant area in various industries, resulting in incredible potential. The streamlined efficiency and predictive performance related to disease diagnosis using AI, chiefly in clinical imaging errands, are equivalence with or even exceed that of doctors, and they are capable of the benefits of being determined and ensuring stable characteristics. AI has attained equivalent performance with that of medical experts in a particular medical sector, and obstetrics and gynecology are among them. Thus, with technological development and interdisciplinary incorporation, AI could propose much more in obstetrics and gynecology. However, more research studies are needed to attest to the usefulness of this technology in real life. The developments until this moment have been tremendous, and even more are expected over the next few years. 

References

  1. Agrawal A, Ambad R, Lahoti R, Muley P, Pande PS.(2022). Role of artificial intelligence in PCOS detection. Journal of Datta Meghe Institute of Medical Sciences University. Apr 1;17(2):491-494.
    View at Publisher | View at Google Scholar
  2. Ahmad Z, Rahim S, Zubair M, Abdul-Ghafar J. (2021). Artificial intelligence (AI) in medicine, current applications and future role with special emphasis on its potential and promise in pathology: present and future impact, obstacles including costs and acceptance among pathologists, practical and philosophical considerations. A comprehensive review. Diagnostic Pathology. 2021 Mar 17;16(1):24.
    View at Publisher | View at Google Scholar
  3. Ahmed MR, Newby S, Potluri P, Mirihanage W, Fernando A.(2024). Emerging Paradigms in Fetal Heart Rate Monitoring: Evaluating the Efficacy and Application of Innovative Textile-Based Wearables. Sensors. Sep 19;24(18):6066.
    View at Publisher | View at Google Scholar
  4. Akazawa M, Hashimoto K.(2020). Artificial intelligence in ovarian cancer diagnosis. Anticancer research. Aug 1;40(8):4795-800.
    View at Publisher | View at Google Scholar
  5. Akter S, Xu D, Nagel SC, Bromfield JJ, Pelch K, Wilshire GB, Joshi T.(2019). Machine learning classifiers for endometriosis using transcriptomics and methylomics data. Frontiers in genetics. Sep 4;10:766.
    View at Publisher | View at Google Scholar
  6. Alharbi F, Vakanski A. (2023) Machine learning methods for cancer classification using gene expression data: A review. Bioengineering. Jan 28;10(2):173.
    View at Publisher | View at Google Scholar
  7. Aljameel SS, Alzahrani M, Almusharraf R, Altukhais M, Alshaia S, Sahlouli H, Aslam N, Khan IU, Alabbad DA, Alsumayt A.(2023). Prediction of preeclampsia using machine learning and deep learning models: a review. Big Data and Cognitive Computing. Feb 9;7(1):32.
    View at Publisher | View at Google Scholar
  8. Arnaout R, Curran L, Zhao Y, Levine JC, Chinn E, Moon-Grady AJ. (2021).An ensemble of neural networks provides expert-level prenatal detection of complex congenital heart disease. Nature medicine. May;27(5):882-91.
    View at Publisher | View at Google Scholar
  9. Asante DB, Calapre L, Ziman M, Meniawy TM, Gray ES. (2020).Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?. Cancer letters. Jan 1;468:59-71
    View at Publisher | View at Google Scholar
  10. Aswathy R, Chalos VA, Suganya K, Sumathi S. (2024).Advancing miRNA cancer research through artificial intelligence: from biomarker discovery to therapeutic targeting. Medical Oncology. Dec 17;42(1):30.
    View at Publisher | View at Google Scholar
  11. Avery JC, Deslandes A, Freger SM, Leonardi M, Lo G, Carneiro G, Condous G, Hull ML, Hull L, Avery J, O’Hara R. (2024).Noninvasive diagnostic imaging for endometriosis part 1: a systematic review of recent developments in ultrasound, combination imaging, and artificial intelligence. Fertility and Sterility. Feb 1;121(2):164-88.
    View at Publisher | View at Google Scholar
  12. Bahado-Singh RO, Ibrahim A, Al-Wahab Z, Aydas B, Radhakrishna U, Yilmaz A, Vishweswaraiah S.(2022). Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer. Scientific Reports. Nov 3;12(1):18625.
    View at Publisher | View at Google Scholar
  13. Balakittnen J, Ekanayake Weeramange C, Wallace DF, Duijf PH, Cristino AS, Hartel G, Barrero RA, Taheri T, Kenny L, Vasani S, Batstone M. (2024). A novel saliva-based miRNA profile to diagnose and predict oral cancer. International Journal of Oral Science. Feb 18;16(1):14.
    View at Publisher | View at Google Scholar
  14. Balayla J, Shrem G. (2019).Use of artificial intelligence (AI) in the interpretation of intrapartum fetal heart rate (FHR) tracings: a systematic review and meta-analysis. Archives of gynecology and obstetrics. Jul;300(1):7-14.
    View at Publisher | View at Google Scholar
  15. Beer L, Martin-Gonzalez P, Delgado-Ortet M, Reinius M, Rundo L, Woitek R, Ursprung S, Escudero L, Sahin H, Funingana IG, Ang JE.(2021). Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer. European radiology. Jun;31(6):3765-3772.
    View at Publisher | View at Google Scholar
  16. Belsti Y, Moran L, Du L, Mousa A, De Silva K, Enticott J, Teede H. (2023).Comparison of machine learning and conventional logistic regression-based prediction models for gestational diabetes in an ethnically diverse population; the Monash GDM Machine learning model. International Journal of Medical Informatics. Nov 1;179:105228.
    View at Publisher | View at Google Scholar
  17. Benacerraf BR, Minton KK, Benson CB, Bromley BS, Coley BD, Doubilet PM, Lee W, Maslak SH, Pellerito JS, Perez JJ, Savitsky E.(2018). Proceedings: Beyond Ultrasound First Forum on improving the quality of ultrasound imaging in obstetrics and gynecology. American Journal of Obstetrics and Gynecology. Jan 1;218(1):19-28.
    View at Publisher | View at Google Scholar
  18. S, Jornea L, Bouteiller D, Touboul C, Puchar A, Daraï E.(2022). MicroRNome analysis generates a blood-based signature for endometriosis. Scientific Reports. Mar 8;12(1):4051
    View at Publisher | View at Google Scholar
  19. Benjamens S, Dhunnoo P, Mesko B. (2020), The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database. NPJ Digital Medicine 3 118.
    View at Publisher | View at Google Scholar
  20. Bertini A, Salas R, Chabert S, Sobrevia L, Pardo F. (2022).Using machine learning to predict complications in pregnancy: a systematic review. Frontiers in bioengineering and biotechnology. Jan
    View at Publisher | View at Google Scholar
  21. Bhattad PB, Jain V. (2020).Artificial Intelligence in Modern Medicine-The Evolving Necessity of the Present and Role in Transforming the Future of Medical Care. Cureus. May 9;12(5):e8041.
    View at Publisher | View at Google Scholar
  22. Boehm KM, Aherne EA, Ellenson L, Nikolovski I, Alghamdi M, Vázquez-García I, Zamarin D, Long Roche K, Liu Y, Patel D, Aukerman A. (2022).Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer. Nature cancer. Jun;3(6):723-33.
    View at Publisher | View at Google Scholar
  23. Boon SS, Luk HY, Xiao C, Chen Z, Chan PK.(2022). Review of the standard and advanced screening, staging systems and treatment modalities for cervical cancer. Cancers. Jun 13;14(12):2913.
    View at Publisher | View at Google Scholar
  24. Brandão M, Mendes F, Martins M, Cardoso P, Macedo G, Mascarenhas T, Mascarenhas Saraiva M. (2024).Revolutionizing Women’s Health: A Comprehensive Review of Artificial Intelligence Advancements in Gynecology. Journal of Clinical Medicine. Feb 13;13(4):1061.
    View at Publisher | View at Google Scholar
  25. Bulun SE, Yilmaz BD, Sison C, Miyazaki K, Bernardi L, Liu S, Kohlmeier A, Yin P, Milad M, Wei J. (2019).Endometriosis. Endocrine reviews. Aug 1;40(4):1048-79.
    View at Publisher | View at Google Scholar
  26. Burgos-Artizzu XP, Coronado-Gutiérrez D, Valenzuela-Alcaraz B, Bonet-Carne E, Eixarch E, Crispi F, Gratacós E. (2020).Evaluation of deep convolutional neural networks for automatic classification of common maternal fetal ultrasound planes. Scientific Reports. Jun 23;10(1):10200.
    View at Publisher | View at Google Scholar
  27. Burgos-Artizzu XP, Perez-Moreno Á, Coronado-Gutierrez D, Gratacos E, Palacio M.(2019). Evaluation of an improved tool for non-invasive prediction of neonatal respiratory morbidity based on fully automated fetal lung ultrasound analysis. Scientific reports. Feb 13;9(1):1950.
    View at Publisher | View at Google Scholar
  28. Cho HC, Sun S, Hyun CM, Kwon JY, Kim B, Park Y, Seo JK. (2021).Automated ultrasound assessment of amniotic fluid index using deep learning. Medical Image Analysis. Apr 1;69:101951
    View at Publisher | View at Google Scholar
  29. Chow DJX, Wijesinghe P, Dholakia K, Dunning KR. Does artificial intelligence have a role in the IVF clinic? Reprod Fertil. 2021 Aug 23;2(3):C29-C34. doi: 10.1530/RAF-21-0043.
    View at Publisher | View at Google Scholar
  30. Daley BJ, Ni’Man M, Neves MR, Bobby Huda MS, Marsh W, Fenton NE, Hitman GA, McLachlan S. mHealth apps for gestational diabetes mellitus that provide clinical decision support or artificial intelligence: a scoping review. Diabetic Medicine. 2022 Jan;39(1):e14735. doi.org/10.1111/dme.14735.
    View at Publisher | View at Google Scholar
  31. Das S, Dey MK, Devireddy R, Gartia MR. Biomarkers in cancer detection, diagnosis, and prognosis. Sensors. 2023 Dec 20;24(1):37. doi.org/10.3390/s24010037.
    View at Publisher | View at Google Scholar
  32. Dellino M, Cerbone M, d’Amati A, Bochicchio M, Laganà AS, Etrusco A, Malvasi A, Vitagliano A, Pinto V, Cicinelli E, Cazzato G.(2024).Artificial Intelligence in Cervical Cancer Screening: Opportunities and Challenges. AI. Dec 23;5(4):2984-3000.
    View at Publisher | View at Google Scholar
  33. Deng ZM, Dai FF, Wang RQ, Deng HB, Yin TL, Cheng YX, Chen GT. (2024).Organ-on-a-chip: future of female reproductive pathophysiological models. Journal of Nanobiotechnology. Jul 31;22(1):455.
    View at Publisher | View at Google Scholar
  34. Dillon EC, Chopra V, Mesghina E, Milki A, Chan A, Reddy R, Kapp DS, Silver BA, Chan JK. (2022).The healthcare journey of women with advanced gynecological cancer from diagnosis through terminal illness: qualitative analysis of progress note data. American Journal of Hospice and Palliative Medicine®. Sep;39(9):1090-7.
    View at Publisher | View at Google Scholar
  35. Ding D, Lang T, Zou D, Tan J, Chen J, Zhou L, Wang D, Li R, Li Y, Liu J, Ma C.(2021). Machine learning-based prediction of survival prognosis in cervical cancer. BMC bioinformatics. Jun 16;22(1):331.
    View at Publisher | View at Google Scholar
  36. Dirie NI, Wang Q, Wang S. (2018). Two-dimensional versus three-dimensional laparoscopic systems in urology: a systematic review and meta-analysis. Journal of Endourology. Sep 1;32(9):781-790.
    View at Publisher | View at Google Scholar
  37. Drukker L, Noble JA, Papageorghiou AT. (2020).Introduction to artificial intelligence in ultrasound imaging in obstetrics and gynecology. Ultrasound in Obstetrics & Gynecology. Oct;56(4):498-505.
    View at Publisher | View at Google Scholar
  38. Edwards LA, Arya B.(2024). Advances in Diagnosis and Management of Fetal Heart Disease. Current Pediatrics Reports. Sep;12(3):89-98.
    View at Publisher | View at Google Scholar
  39. Farahani H, Boschman J, Farnell D, Darbandsari A, Zhang A, Ahmadvand P, Jones SJ, Huntsman D, Köbel M, Gilks CB, Singh N.(2022). Deep learning-based histotype diagnosis of ovarian carcinoma whole-slide pathology images. Modern Pathology. Dec 1;35(12):1983-90.
    View at Publisher | View at Google Scholar
  40. Fernandez EI, Ferreira AS, Cecilio MHM, Cheles DS, de Souza RCM, Nogueira MFG, Rocha JC.( 2020). Artificial intelligence in the IVF laboratory: overview through the application of different types of algorithms for the classification of reproductive data. Journal of Assisted Reproduction and Genetics, 372359–2376.
    View at Publisher | View at Google Scholar
  41. Fiorentino MC, Villani FP, Di Cosmo M, Frontoni E, Moccia S.(2023). A review on deep-learning algorithms for fetal ultrasound-image analysis. Medical image analysis. Jan 1; 83:102629.
    View at Publisher | View at Google Scholar
  42. Gandotra S, Kumar Y, Modi N, Choi J, Shafi J, Ijaz MF.( 2024). Comprehensive analysis of artificial intelligence techniques for gynaecological cancer: symptoms identification, prognosis and prediction. Artificial Intelligence Review. Jul 29;57(8):220.
    View at Publisher | View at Google Scholar
  43. Ganesh AD, Kalpana P. (2022).Future of artificial intelligence and its influence on supply chain risk management–A systematic review. Computers & Industrial Engineering. Jul 1;169:108206.
    View at Publisher | View at Google Scholar
  44. Gbagbo FY, Ameyaw EK, Yaya S. (2024).Artificial intelligence and sexual reproductive health and rights: a technological leap towards achieving sustainable development goal target 3.7. Reproductive Health. Dec 23;21(1):196.
    View at Publisher | View at Google Scholar
  45. Ghaffar Nia N, Kaplanoglu E, Nasab A. (2023).Evaluation of artificial intelligence techniques in disease diagnosis and prediction. Discover Artificial Intelligence. Jan 30;3(1):5.
    View at Publisher | View at Google Scholar
  46. Gholipour M, Khajouei R, Amiri P, Hajesmaeel Gohari S, Ahmadian L. (2023).Extracting cancer concepts from clinical notes using natural language processing: a systematic review. BMC bioinformatics. Oct 29;24(1):405.
    View at Publisher | View at Google Scholar
  47. Giudice LC, Oskotsky TT, Falako S, Opoku‐Anane J, Sirota M. (2023).Endometriosis in the era of precision medicine and impact on sexual and reproductive health across the lifespan and in diverse populations. The FASEB Journal. Sep;37(9): e23130.
    View at Publisher | View at Google Scholar
  48. Grandjean GA, Hossu G, Bertholdt C, Noble P, Morel O, Grangé G. (2018).Artificial intelligence assistance for fetal head biometry: assessment of automated measurement software. Diagnostic and interventional imaging. Nov 1;99(11):709-16.
    View at Publisher | View at Google Scholar
  49. Guixue G, Yifu P, Yuan G, Xialei L, Fan S, Qian S, Jinjin X, Linna Z, Xiaozuo Z, Wen F, Wen Y.(2018). Progress of the application clinical prediction model in polycystic ovary syndrome. Journal of Ovarian Research. 2023 Nov 25;16(1):230
    View at Publisher | View at Google Scholar
  50. Gumbs AA, Frigerio I, Spolverato G, Croner R, Illanes A, Chouillard E, Elyan E. (2021).Artificial intelligence surgery: How do we get to autonomous actions in surgery?. Sensors. Aug 17;21(16):5526.
    View at Publisher | View at Google Scholar
  51. Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P. (2021).Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Molecular Diversity. Apr 12;25(3):1315-60.
    View at Publisher | View at Google Scholar
  52. Han X, Yu J, Yang X, Chen C, Zhou H, Qiu C, Cao Y, Zhang T, Peng M, Zhu G, Ni D.(2024) Artificial intelligence assistance for fetal development: evaluation of an automated software for biometry measurements in the mid-trimester. BMC Pregnancy and Childbirth. Feb 23;24(1):158.
    View at Publisher | View at Google Scholar
  53. Hatamikia S, Nougaret S, Panico C, Avesani G, Nero C, Boldrini L, Sala E, Woitek R. (2023).Ovarian cancer beyond imaging: integration of AI and multiomics biomarkers. European Radiology Experimental. Sep 13;7(1):50.
    View at Publisher | View at Google Scholar
  54. Hunter B, Hindocha S, Lee RW. The role of artificial intelligence in early cancer diagnosis. Cancers. 2022 Mar 16;14(6):1524.
    View at Publisher | View at Google Scholar
  55. Iftikhar M, Saqib M, Zareen M, Mumtaz H.(2024). Artificial intelligence: revolutionizing robotic surgery. Annals of Medicine and Surgery. Sep 1;86(9):5401-9.
    View at Publisher | View at Google Scholar
  56. Iftikhar P, Kuijpers MV, Khayyat A, Iftikhar A, De Sa MD.(2020).Artificial intelligence: a new paradigm in obstetrics and gynecology research and clinical practice. Cureus. Feb;12(2): e7124.
    View at Publisher | View at Google Scholar
  57. Jain A, Chauhan D, Singh RK, Kaur M, Septa A. (2024).Role of Artificial Intelligence in Health care System. International Journal of Pharma Professional’s Research (IJPPR). 15(1):27-40.
    View at Publisher | View at Google Scholar
  58. Jost E, Kosian P, Jimenez Cruz J, Albarqouni S, Gembruch U, Strizek B, Recker F.(2023). Evolving the era of 5D ultrasound? A systematic literature review on the applications for artificial intelligence ultrasound imaging in obstetrics and gynecology. Journal of Clinical Medicine. Oct 29;12(21):6833
    View at Publisher | View at Google Scholar
  59. Kalra N, Verma P, Verma S.(2024). Advancements in AI based healthcare techniques with FOCUS ON diagnostic techniques. Computers in Biology and Medicine. Sep 1;179:108917.
    View at Publisher | View at Google Scholar
  60. Kannaiyan A, Bagchi S, Vijayan V, Georgiy P, Manickavasagam S, Kumar DS. (2024).Revolutionizing Women\'s Health: Artificial Intelligence\'s Impact on Obstetrics and Gynecology. Journal of South Asian Federation of Obstetrics and Gynaecology. Feb 23;16(2):161-8.
    View at Publisher | View at Google Scholar
  61. Kawakami E, Tabata J, Yanaihara N, Ishikawa T, Koseki K, Iida Y, Saito M, Komazaki H, Shapiro JS, Goto C, Akiyama Y.(2019). Application of artificial intelligence for preoperative diagnostic and prognostic prediction in epithelial ovarian cancer based on blood biomarkers. Clinical cancer research. May 15;25(10):3006-15.
    View at Publisher | View at Google Scholar
  62. Khalili N, Turk E, Benders MJ, Moeskops P, Claessens NH, de Heus R, Franx A, Wagenaar N, Breur JM, Viergever MA, Išgum I. (2019).Automatic extraction of the intracranial volume in fetal and neonatal MR scans using convolutional neural networks. NeuroImage: Clinical. Jan 1;24:102061..
    View at Publisher | View at Google Scholar
  63. Khan I, Khare BK. (2024).Exploring the potential of machine learning in gynecological care: a review. Archives of gynecology and obstetrics. Jun;309(6):2347-2365
    View at Publisher | View at Google Scholar
  64. Khanna VV, Chadaga K, Sampathila N, Prabhu S, Bhandage V, Hegde GK. A distinctive explainable machine learning framework for detection of polycystic ovary syndrome. Applied System Innovation. 2023 Feb 23;6(2):32. doi.org/10.3390/asi6020032.
    View at Publisher | View at Google Scholar
  65. Kim HY, Cho GJ, Kwon HS. Applications of artificial intelligence in obstetrics. Ultrasonography. 2022 Jul 20;42(1):2. doi: 10.14366/usg.22063.
    View at Publisher | View at Google Scholar
  66. Kiser AC, Schliep KC, Hernandez EJ, Peterson CM, Yandell M, Eilbeck K. (2024).An artificial intelligence approach for investigating multifactorial pain-related features of endometriosis. Plos one. Feb 21;19(2):e0297998.
    View at Publisher | View at Google Scholar
  67. Laios A, De Oliveira Silva RV, Dantas De Freitas DL, Tan YS, Saalmink G, Zubayraeva A, Johnson R, Kaufmann A, Otify M, Hutson R, Thangavelu A. (2021).Machine learning-based risk prediction of critical care unit admission for Advanced Stage High Grade Serous Ovarian Cancer patients undergoing cytoreductive Surgery: the Leeds-Natal score. Journal of Clinical Medicine. Dec 24;11(1):87.
    View at Publisher | View at Google Scholar
  68. Lee KS, Ahn KH. (2020).Application of artificial intelligence in early diagnosis of spontaneous preterm labor and birth. Diagnostics. Sep 22;10(9):733.
    View at Publisher | View at Google Scholar
  69. Li C, Chen H, Li X, Xu N, Hu Z, Xue D, Qi S, Ma H, Zhang L, Sun H. (2020).A review for cervical histopathology image analysis using machine vision approaches. Artificial Intelligence Review. Oct;53:4821-62.
    View at Publisher | View at Google Scholar
  70. Li H, Zhang R, Li R, Xia W, Chen X, Zhang J, Cai S, Zhao S, Qiang J, Peng W, Gu Y. (2021).Noninvasive prediction of residual disease for advanced high-grade serous ovarian carcinoma by MRI-based radiomic-clinical nomogram. European radiology. Oct;31(10):7855-64.
    View at Publisher | View at Google Scholar
  71. Li P, Hu Y, Liu ZP. (2021).Prediction of cardiovascular diseases by integrating multi-modal features with machine learning methods. Biomedical Signal Processing and Control. Apr 1;66:102474.
    View at Publisher | View at Google Scholar
  72. Liu L, Jiao Y, Li X, Ouyang Y, Shi D. (2020). Machine learning algorithms to predict early pregnancy loss after in vitro fertilization-embryo transfer with fetal heart rate as a strong predictor. Computer Methods and Programs in Biomedicine. Nov 1;196:105624.
    View at Publisher | View at Google Scholar
  73. Lu Y, Zhi D, Zhou M, Lai F, Chen G, Ou Z, Zeng R, Long S, Qiu R, Zhou M, Jiang X.(2022). Multitask deep neural network for the fully automatic measurement of the angle of progression. Computational and mathematical methods in medicine. (1):5192338.
    View at Publisher | View at Google Scholar
  74. Ma Y, Zhu H, Yang Z, Wang D.( 2022). Optimizing the Prognostic Model of Cervical Cancer Based on Artificial Intelligence Algorithm and Data Mining Technology. Wireless Communications and Mobile Computing.;2022(1):5908686.
    View at Publisher | View at Google Scholar
  75. Malani IV SN, Shrivastava D, Raka MS. (2023).A comprehensive review of the role of artificial intelligence in obstetrics and gynecology. Cureus. Feb;15(2): e34891.
    View at Publisher | View at Google Scholar
  76. Mapari SA, Shrivastava D, Bedi GN, Pradeep U, Gupta A, Kasat PR, Sachani P.(2024). Revolutionizing Reproduction: The Impact of Robotics and Artificial Intelligence (AI) in Assisted Reproductive Technology: A Comprehensive Review. Cureus. Jun 24;16(6):e63072.
    View at Publisher | View at Google Scholar
  77. Mertes G, Long Y, Liu Z, Li Y, Yang Y, Clifton DA. A (2022).deep learning approach for the assessment of signal quality of non-invasive foetal electrocardiography. Sensors. Apr 26;22(9):3303.
    View at Publisher | View at Google Scholar
  78. Meyer-Szary J, Luis MS, Mikulski S, Patel A, Schulz F, Tretiakow D, Fercho J, Jaguszewska K, Frankiewicz M, Pawłowska E, Targoński R. (2022).The role of 3D printing in planning complex medical procedures and training of medical professionals—cross-sectional multispecialty review. International journal of environmental research and public health. Mar 11;19(6):3331.
    View at Publisher | View at Google Scholar
  79. Moawad G, Tyan P, Louie M. Artificial intelligence and augmented reality in gynecology. Current Opinion in Obstetrics and Gynecology. 2019 Oct 1;31(5):345-348.
    View at Publisher | View at Google Scholar
  80. Nie S, Yu J, Chen P, Wang Y, Zhang JQ. (2017).Automatic detection of standard sagittal plane in the first trimester of pregnancy using 3-D ultrasound data. Ultrasound in medicine & biology. Jan 1;43(1):286-300.
    View at Publisher | View at Google Scholar
  81. Ouh YT, Kim HY, Yi KW, Lee NW, Kim HJ, Min KJ. (2024).Enhancing cervical cancer screening: review of p16/Ki-67 dual staining as a promising triage strategy. Diagnostics. Feb 19;14(4):451.
    View at Publisher | View at Google Scholar
  82. Patel DJ, Chaudhari K, Acharya N, Shrivastava D, Muneeba S.(2024). Artificial Intelligence in Obstetrics and Gynecology: Transforming Care and Outcomes. Cureus. Jul 17;16(7):e64725.
    View at Publisher | View at Google Scholar
  83. Pisapia JM, Akbari H, Rozycki M, Goldstein H, Bakas S, Rathore S, Moldenhauer JS, Storm PB, Zarnow DM, Anderson RC, Heuer GG. (2018).Use of fetal magnetic resonance image analysis and machine learning to predict the need for postnatal cerebrospinal fluid diversion in fetal ventriculomegaly. JAMA pediatrics. Feb 1;172(2):128-35.
    View at Publisher | View at Google Scholar
  84. Prabha C. (2024).Role of artificial intelligence in gynecology and obstetrics. InArtificial Intelligence and Machine Learning for Women’s Health Issues Jan 1 (pp. 1-15). Academic Press.
    View at Publisher | View at Google Scholar
  85. Prapty AS, Shitu TT. (2020).An efficient decision tree establishment and performance analysis with different machine learning approaches on polycystic ovary syndrome. In2020 23rd International conference on computer and information technology (ICCIT) Dec 19 (pp. 1-5). IEEE.
    View at Publisher | View at Google Scholar
  86. Qi X. (2024).Artificial intelligence-assisted magnetic resonance imaging technology in the differential diagnosis and prognosis prediction of endometrial cancer. Scientific Reports. Nov 6;14(1):26878.
    View at Publisher | View at Google Scholar
  87. Rajkomar A, Dean J, Kohane I. Machine learning in medicine. New England Journal of Medicine. 2019 Apr 4;380(14):1347-58.
    View at Publisher | View at Google Scholar
  88. Rajpurkar P, Chen E, Banerjee O, Topol EJ. (2022).AI in health and medicine. Nature medicine. Jan;28(1):31-8.
    View at Publisher | View at Google Scholar
  89. Rathod S, Shanoo A, Acharya N. Endometriosis: A Comprehensive Exploration of Inflammatory Mechanisms and Fertility Implications. Cureus. 2024 Aug 4;16(8):e66128.
    View at Publisher | View at Google Scholar
  90. Safiullina ER, Rychkova EI, Mayorova IV, Khairutdinova DK, Slonskaya AA, Faronova AS, Davydova YA, Mussova IA. (2023).Application of digital methods and artificial intelligence capabilities for diagnostics in obstetrics and gynecology. Cardiometry. May 1(27):111-7.
    View at Publisher | View at Google Scholar
  91. Salini Y, Mohanty SN, Ramesh JV, Yang M, Chalapathi MM. (2024).Cardiotocography Data Analysis for Fetal Health Classification Using Machine Learning Models. IEEE Access.;12:26005-22.
    View at Publisher | View at Google Scholar
  92. Sarno L, Neola D, Carbone L, Saccone G, Carlea A, Miceli M, Iorio GG, Mappa I, Rizzo G, Di Girolamo R, D'Antonio F.(2023).Use of artificial intelligence in obstetrics: not quite ready for prime time. American Journal of Obstetrics & Gynecology MFM. Feb 1;5(2):100792.
    View at Publisher | View at Google Scholar
  93. Sulas E, Ortu E, Urru M, Tumbarello R, Raffo L, Solinas G, Pani D.(2021). Impact of pulsed-wave-Doppler velocity-envelope tracing techniques on classification of complete fetal cardiac cycles. Plos one. Apr 28;16(4):e0248114.
    View at Publisher | View at Google Scholar
  94. Vaidya T, Patil AN, Mankad K, Aghade AA, Tambade VR. (2024).The role of Artificial Intelligence in Improving Maternal Fetal Health Outcomes: A Mini Review. Archives of Medical Reports. Jul 31;1(2):9-12.
    View at Publisher | View at Google Scholar
  95. Vávra P, Roman J, Zonča P, Ihnát P, Němec M, Kumar J, Habib N, El-Gendi A. (2017).Recent development of augmented reality in surgery: a review. Journal of healthcare engineering.;2017(1):4574172.
    View at Publisher | View at Google Scholar
  96. Vemulavada S, Karthikvatsan S, Babu A, Kadalmani B, Devi TR, Sasipraba T, Manikkam R, Parthasarathy K, Balaji VH. (2024).Role of Artificial Intelligence in the Diagnosis and Therapy of Gynecological Disorders: Opportunities and Challenges. Translational Research in Biomedical Sciences: Recent Progress and Future Prospects. Aug 30; 10:121-44.
    View at Publisher | View at Google Scholar
  97. Verma P, Maan P, Gautam R, Arora T. (2024).Unveiling the role of artificial intelligence (AI) in polycystic ovary syndrome (PCOS) diagnosis: A comprehensive review. Reproductive Sciences. Oct;31(10):2901-15.
    View at Publisher | View at Google Scholar
  98. Vickers H, Jha S. (2020).Medicolegal issues in gynaecology. Obstetrics, Gynaecology & Reproductive Medicine. Feb 1;30(2):43-7.
    View at Publisher | View at Google Scholar
  99. Vollset SE, Goren E, Yuan CW, Cao J, Smith AE, Hsiao T, Bisignano C, Azhar GS, Castro E, Chalek Jet al.(2020). Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study. Lancet, 3961285–1306.
    View at Publisher | View at Google Scholar
  100. Wang C, Zhu X, Hong JC, Zheng D. (2019).Artificial intelligence in radiotherapy treatment planning: present and future. Technology in Cancer Research and Treatment, , 181533033819873922.
    View at Publisher | View at Google Scholar
  101. Wang G, Liu X, Zhu S, Lei J. (2023).Experience of mental health in women with Polycystic Ovary Syndrome: a descriptive phenomenological study. Journal of Psychosomatic Obstetrics & Gynecology. Dec 31;44(1):2218987.
    View at Publisher | View at Google Scholar
  102. Weichert A, Gembicki M, Weichert J, Weber SC, Koenigbauer J. (2023).Semi-automatic measurement of fetal cardiac axis in fetuses with congenital heart disease (CHD) with fetal intelligent navigation echocardiography (FINE). Journal of Clinical Medicine. Oct 5;12(19):6371.
    View at Publisher | View at Google Scholar
  103. Williams P, Murchie P, Bond C. (2019).Patient and primary care delays in the diagnostic pathway of gynaecological cancers: a systematic review of influencing factors. British Journal of General Practice. Feb 1;69(679):e106-11.
    View at Publisher | View at Google Scholar
  104. Wu M, Zhao Y, Dong X, Jin Y, Cheng S, Zhang N, Xu S, Gu S, Wu Y, Yang J, Yao L. (2022).Artificial intelligence-based preoperative prediction system for diagnosis and prognosis in epithelial ovarian cancer: A multicenter study. Frontiers in Oncology. Sep 21;12:975703.
    View at Publisher | View at Google Scholar
  105. Wu T, Lucas E, Zhao F, Basu P, Qiao Y. (2024).Artificial intelligence strengthenes cervical cancer screening–present and future. Cancer Biology & Medicine. Sep 19;21(10):864.
    View at Publisher | View at Google Scholar
  106. Xu HL, Gong TT, Liu FH, Chen HY, Xiao Q, Hou Y, Huang Y, Sun HZ, Shi Y, Gao S, Lou Y. (2022).Artificial intelligence performance in image-based ovarian cancer identification: A systematic review and meta-analysis. EClinicalMedicine. Sep 17;53:101662
    View at Publisher | View at Google Scholar
  107. Yang Y, Guan S, Ou Z, Li W, Yan L, Situ B. (2023).Advances in AI‐based cancer cytopathology. Interdisciplinary Medicine. Jul;1(3):e20230013..
    View at Publisher | View at Google Scholar
  108. Yousefpour Shahrivar R, Karami F, Karami E.( 2023). Enhancing Fetal Anomaly Detection in Ultrasonography Images: A Review of Machine Learning-Based Approaches. Biomimetics. Nov 2;8(7):519.
    View at Publisher | View at Google Scholar
  109. Zeng LH, Rana S, Hussain L, Asif M, Mehmood MH, Imran I, Younas A, Mahdy A, Al-Joufi FA, Abed SN. (2022).Polycystic ovary syndrome: a disorder of reproductive age, its pathogenesis, and a discussion on the emerging role of herbal remedies. Frontiers in Pharmacology. Jul 18;13:874914.
    View at Publisher | View at Google Scholar
  110. Zhang Y, Ma W, Huang Z, Liu K, Feng Z, Zhang L, Li D, Mo T, Liu Q. (2024).Research and application of omics and artificial intelligence in cancer. Physics in Medicine & Biology. Oct 18;69(21):21TR01. DOI 10.1088/1361-6560/ad6951
    View at Publisher | View at Google Scholar
a